Table 5 China’s GDP and pharmaceutical expenditure (US$, millions, nominal)
From: Healthcare reform in the United States and China: pharmaceutical market implications
China GDP | Total health spending | Healthcare as % of GDP | Prescription drugs | |
|---|---|---|---|---|
2000 | 1,198,475 | 55,404 | 4.6% | 13,850 |
2005 | 2,257,619 | 105,716 | 4.7% | 25,340 |
2010 | 5,931,203 | 295,153 | 5.0% | 60,270 |
2011 | 7,324,952 | 369,910 | 5.1% | 77,300 |
2012 | 8,226,885 | 419,571 | 5.2% | 91,980 |
2015 | 10,220,234 | 715,416 | 7.0% | 158,940 |
2020 | 14,672,467 | 1,247,160 | 8.5% | 261,840 |